Wire · regulatory
Justice Nominee Solicits Clinical Trial Approval During Parliamentary Audit
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 September 2026 · Fusion42 review
Kim Seung-won, nominee for Minister of Justice in South Korea, was alleged to solicit clinical trial approval for Genencell from the head of the Ministry of Food and Drug Safety during a parliamentary audit, raising concerns of regulatory impropriety. The clinical trial was approved shortly after, with subsequent revelations about data deletions by Genencell's founder.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 1 source has reported it between 6 Sep 2026 and 10 Sep 2026.
◆ ◆ The Wire takeaway
Your regulatory approvals in South Korea just got a new risk factor as political interference surfaced at ministerial level, signalling stricter scrutiny ahead for clinical trial startups. Expect delays and reputational hurdles that could reshape your government engagement strategy.
◆ Coverage
1 source · first reported 6 Sep 2026 · latest 10 Sep 2026
◆ Related on Wire
◆ Topics